The Pharmaceutical Healthcare Association of the Philippines, which includes many international research-based drugmakers, has organized an anti-counterfeiting seminar in Pangasinan, the Philippines, in conjunction with the country's Bureau of Food and Drugs.
The theme of the gathering was the "need for collaboration between the different sectors of the industry and the different government agencies to fight against counterfeit drugs," according to Eufe Tantia, the PHAP's assistant vice president.
Another speaker, Nazarita Lanuza, the BFAD's Division I regulation director, spoke of joint actions taken by her bureau and the Drugstores Association of the Philippines, whose local members were the invitees of the seminar. Ms Lanuza outlined actions, such as: the licensing and inspection of production and distribution points; product registration and monitoring; sampling for quality control; the proper disposal of used empty vials; educating law enforcement agencies; and the creation of an Internet-based rapid alert system for fake drugs.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze